07
Jan

Zafgen charted a third major victory for its in-development obesity drug, spurring weight loss for patients who have endured brain injuries and stoking hopes for success in Phase III.

…read more

Source: Zafgen’s promising obesity drug comes through in another midstage trial

    

0 No comments